№ lp_2_3_48136
Supplemental research figures and tables presenting in vitro and in vivo experiments evaluating WSD0628 as a radiosensitizer, including kinase inhibition, DNA damage response, tumor growth, and survival outcomes in brain tumor models.
Year: 2026
Region / City: Rochester, Minnesota, USA; Jinan, Shandong, China; Minneapolis, Minnesota, USA; Corona, California, USA
Subject: Oncology, Radiobiology, Pharmacology
Document Type: Supplemental Data / Research Figures and Tables
Institution: Mayo Clinic; Cheeloo College of Medicine, Shandong University; University of Minnesota; Wayshine Biopharm Inc
Authors: Zhiyi Xue, Ann C. Mladek, Sneha Rathi, Sonia Jain, Rachael A. Vaubel, Lateef A. Odukoya, Darwin A. Garcia, Lily Liu, Katrina K. Bakken, Brett L. Carlson, Lauren L. Ott, Danielle M. Burgenske, Zeng Hu, Sonja Dragojevic, Paul A. Decker, Matthew L. Kosel, William G. Breen, Shiv K. Gupta, Jeanette E. Eckel-Passow, William F. Elmquist, Wei Zhong, Jann N. Sarkaria
Target Audience: Researchers in oncology and pharmacology
Experimental Models: U251, GBM43, GBM120, GBM12, M12eGFP-fLuc2 cell lines; mouse orthotopic xenografts
Treatment Interventions: WSD0628, radiation therapy, DDR inhibitors
Assays and Measurements: TR-FRET kinase assay, Western blotting, histological evaluation, survival analysis
Statistical Methods: Two-sample t-test, median and mean ± SD reporting
Period of Study: 2026
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.